{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
... is a targeted resequencing assay for research of somatic and germline variants across BRCA1 and BRCA2 genes. Key features include: Relevant Gene Content Target all exonic regions and flanking intronic ...
Illumina, Inc.
... somatic mutations across the hotspot regions of 50 genes with known associations to cancer, as identified in the Catalogue of Somatic Mutations in Cancer (COSMIC)1 database. Key features include: Relevant Gene ...
Illumina, Inc.
... Illumina Comprehensive Panel v3 offers coverage of key cancer genes, including kinase domains and genes involved in DNA repair. Relevant Gene Content Target 161 unique cancer-associated ...
Illumina, Inc.
... technology, even from low-quality starting materials such as formalin-fixed, paraffin-embedded (FFPE) tissues. Include only the genes and targets of interest Easily design custom content with DesignStudio, a free, ...
Illumina, Inc.
... biomarker analysis of 52 genes with known relevance to solid tumors. Using the Focus Panel, researchers can analyze both DNA and RNA concurrently. Key features include: Relevant Gene Content Target ...
Illumina, Inc.
... resequencing research assay for quantitating expression of cancer biomarkers in 395 genes involved in tumor–immune system interactions. Panel features Relevant Gene Content - Targeted expression ...
Illumina, Inc.
... sequence a variety of genes and single nucleotide polymorphisms (SNPs) previously linked to cancer predisposition. Targets 94 genes and 284 SNPs associated with a predisposition towards cancer TruSight ...
Illumina, Inc.
... a real-time PCR assay to evaluate the quality of prospective DNA samples. The assay utilizes standard instrumentation and reagents from an authorized vendor. Each kit provides primers and DNA template for 384 reactions. Repair ...
Illumina, Inc.
Please specify:
Help us improve:
remaining